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The comprehensive mapping of gene promoters and enhancers has significantly improved our
understanding of how the mammalian regulatory genome is organized. An important challenge is
to elucidate how these regulatory elements contribute to gene expression by identifying their
trans-regulatory inputs. Here, we present the generation of a mouse-specific transcription factor
(TF) open-reading frame clone library and its implementation in yeast one-hybrid assays to enable
large-scale protein–DNA interaction detection with mouse regulatory elements. Once specific
interactions are identified, we then use a microfluidics-based method to validate and precisely map
them within the respective DNA sequences. Using well-described regulatory elements as well as
orphan enhancers, we show that this cross-platform pipeline characterizes known and uncovers
many novel TF–DNA interactions. In addition, we provide evidence that several of these novel
interactions are relevant in vivo and aid in elucidating the regulatory architecture of enhancers.
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Introduction
Since the original discovery of a cellular enhancer (Banerji
et al, 1983), the mouse has been an excellent model organism
for studying metazoan gene regulation, especially mamma-
lian-specific complex biological processes, due to the avail-
ability of tissues and ease of genomic manipulation (Paigen,
2003; Stamatoyannopoulos et al, 2012). An example of the
latter is the ability to characterize the transcriptional activity of
putative gene regulatory elements in vivo. In recent years, such
elements have been identified in increasing numbers and at a
genome-wide level through computational approaches (Siepel
et al, 2005; Hallikas et al, 2006; Birney et al, 2007; Ferretti et al,
2007), co-regulator or histone modification mapping (Birney
et al, 2007; Heintzman et al, 2009; Visel et al, 2009; Shen et al,
2012; Raghav et al, 2012), and large-scale initiatives such as
the mouse ENCODE will further expand this element catalog
(Stamatoyannopoulos et al, 2012). Together with studies
revealing the genome-wide location of gene promoters in the
mouse (Carninci et al, 2006), these efforts have already led
to a better knowledge of the regulatory architecture of the
mammalian genome. To understand how regulatory elements
contribute to gene expression, we now need to elucidate the
transcription factors (TFs) that bind to them (Nam et al, 2010).
The most convenient strategy to identify trans-regulatory
inputs has typically been the computational prediction of TF
binding sites within the regulatory elements of interest
(Wasserman and Sandelin, 2004). Specifically, elements are
scanned for potential TF binding sites using positional weight
matrices (PWMs), which represent the DNA binding specifi-
cities of TFs (Stormo and Zhao, 2010). A recent comparison of
such computational scanning tools revealed that the best
performing ones achieved high prediction accuracy, although
non-negligible discrepancies between experimentally- and
in silico-derived data remained (Weirauch et al, 2013).
Consequently, downstream experimental validation will
always be required to conclusively identify implicated TFs.
In addition, despite valuable efforts (Berger et al, 2008; Noyes
et al, 2008; Jolma et al, 2013), the binding specificities of the
majority of mammalian TFs have still not been characterized.
Identifying TF–DNA interactions based on PWMmodels alone
will therefore leave a significant portion of the regulatory
space unprobed.
An alternative approach to link TFs with regulatory
elements involves the use of protein-centered protein–DNA
interaction detection methods such as chromatin immunopre-
cipitation (ChIP) coupled to high-throughput sequencing
(ChIP-seq) (Johnson et al, 2007; Robertson et al, 2007).
However, ChIP-seq has a low throughput on the TF side, is
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restricted by the availability of TF-specific antibodies, and
often fails when targeted TFs are, for example, expressed in a
small time window or in a limited number of cells (Deplancke,
2009; Farnham, 2009). This explains why the transcriptional
activity for only amoderate number of regulatory elements has
so far been linked to the binding of specific TFs using ChIP-seq.
To alleviate some of the issues associated with motif-based or
protein-centered TF–regulatory element interaction identifica-
tion, we and others have previously developed DNA-centered
yeast one-hybrid (Y1H)-based methods that allow the large-
scale detection of human (Reece-Hoyes et al, 2011a), Droso-
phila melanogaster (Hens et al, 2011), and Caenorhabditis
elegans (Deplancke et al, 2004; Reece-Hoyes et al, 2011b)
proteins that bind to DNA elements of interest. For each of
these species, comprehensive TF open-reading frame (ORF)
clone libraries were generated so that in principle any
regulatory element can be screened against the majority of
TFs of the respective species in a PWM-independent manner.
Surprisingly, however, there has so far not been a concerted
effort to build a similar toolkit for mouse (Mus musculus),
‘despite’ significant on-going efforts such as the mouse
ENCODE (Stamatoyannopoulos et al, 2012).
With the aim of characterizing predicted mammalian
regulatory elements, especially those that exhibit transcrip-
tional activity in vivo, we have generated a mouse-specific
TF ORF library and employed it in Y1H assays, enabling large-
scale protein-DNA interaction identification for the mouse.
Building on pioneering work in D. melanogaster (Hens et al,
2011), we also show how our Y1H system can be coupled to a
microfluidics-based protein–DNA interaction mapping assay,
MITOMI-based Analysis of Regulatory Elements (MARE).
MARE enables the simultaneous monitoring of 4700
protein–DNA interactions, rendering this technology ideal to
systematically scan relatively long (B1 kb) regulatory ele-
ments for DNA occupancy of specific TFs. MARE is therefore
complementary to the Y1H assay because it allows the
validation of Y1H-detected interactions and hence the filtering
of potential false positives (Hens et al, 2011). In addition,
MARE enables fine-grained mapping of detected interactions,
and thus offers far greater individual TF binding site resolution
than Y1H. Our Y1H and MARE methods therefore constitute a
powerful cross-platform pipeline to experimentally character-
ize the mammalian regulatory elements of interest for
interacting TFs at unprecedented throughput and resolution.
Results
A Gateway-compatible mouse TF ORF clone
resource
We have generated a comprehensive, Gateway-compatible
mouse (Mus musculus) TF ORF clone resource. On the basis of
manual curation and previously published bioinformatics
analyses (Kummerfeld and Teichmann, 2006), we identified
1576 TF-coding genes in the mouse genome (Materials
and methods). We retrieved the cDNA templates for 1260
TFs (B80%) and could derive ORFs for 1014 (B64%) of
them using PCR and Gateway cloning. Using a high-
throughput sequencing-based sequence identification
approach (Massouras et al, 2010), we were able to verify that
750 (B48%) of these TF ORF clones contain the respective
full-length reference ORF sequence (Figure 1A; Supplementary
Table S1). While large-scale efforts have previously been
undertaken to clone all mouse cDNAs (Fantom Consortium,
2005), the presented work represents to our knowledge the
first systematic effort of generating a mouse-specific, Gateway-
compatible, and fully sequence-verified TF ORF library.
Benchmarking of the mouse yeast one-hybrid
assay
To perform large-scale Y1H assays, we considered two
different, but complementary screening formats (Figure 1B).
The first is the diploid yeast-based screening of DNA elements
in which yeast strains containing one DNA bait linked to a
reporter gene (e.g., HIS3) are mated with an array of TF-
expressing (i.e., prey) yeast strains. This strategy has the
advantage of being cost- and throughput-effective and can be
scaled up to accommodate a great number of prey proteins
(Vermeirssen et al, 2007; Reece-Hoyes et al, 2011b). However, it
is relatively labor-intensive due to themany intermediate steps
between the mating and final selection phase, and thus
difficult to completely automate. We therefore also considered
a yeast-based matrix screening format, in which TFs are
individually transformed into haploid, DNA element-contain-
ing yeast strains. While in practice more labor and cost
intensive than mating, we have recently automated and
miniaturized this matrix-based screening process, now
enabling the hands-off screening of DNA elements versus a
large array of TFs (Materials and methods; Hens et al, 2011).
To compare and validate these two strategies for mouse
protein–DNA interaction detection studies, we selected 10
DNA baits. Eight of these are well-characterized regulatory
elements for which several interactors have been identified
using different types of protein–DNA interaction detection
methods (Supplementary Table S2; Materials and methods).
These interactors can be used as positive controls, allowing us
to assess the performance of our Y1H platform. To illustrate the
discovery potential of our Y1H set-up, we also included two
randomly selected orphan enhancers that were shown to
exhibit regulatory activity in mouse transgenic assays (Visel
et al, 2009). Three of the ten baits, including one enhancer,
exhibited high self-activation activity and were eliminated
from further analyses. The remaining elements were screened
versus a mouse-specific array of 745 TFs, which was generated
by transferring all 750 sequence-verified TF ORFs to Y1H-
compatible destination vectors (Figure 1A; Supplementary
Table S1). We identified 40 protein–DNA interactions invol-
ving 25 distinct TFs and 7 DNA baits. The results of two
independent screens involving these DNA baits are presented
in Table I, Figure 2, and Supplementary Figures S1–S7.
On the basis of these data, four conclusions can be drawn:
first, direct transformation tends to yield a greater number of
positive interactions per screen compared with the mating
procedure (Figure 2; Table I, last row; Supplementary Table S3),
consistent with previous results in C. elegans (Vermeirssen
et al, 2007). However, mating results tend to be more
reproducible as most of the interactions found in the first
mating screen were also detected in the second (Table I, last
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row, columns three and seven). One possible reason for
the observed difference in interaction reproducibility between
the two Y1H screening procedures may be that TFs are
re-introduced into fresh yeast strains in the transformation
procedure, whereas the same TF-containing yeast strains are
typically used to repeat the mating screen (Figure 1B; Materials
and methods). Second, among the reproducibly detected
interactions found by either mating or transformation, only
Figure 1 Mouse Y1H pipeline. (A) Workflow to retrieve the mouse TF open-reading frame (ORF) clone resource. We predict that the mouse genome contains 1576
TF-coding genes (Materials and methods). We were able to retrieve cDNA templates for 1260 of these. To initiate the cloning of the corresponding ORFs, we first applied
a strong selection scheme choosing the longest ORF per TF containing the respective DBD. After filtering, 1218 TF cDNA templates were retained. So far, 1014 TF
ORFs have been cloned. The corresponding entry clones were sequence verified using high-throughput sequencing. In all, 150 and 750 TFs were, respectively, partially
or fully sequence verified. (B) The mouse Y1H screening pipeline using either the mating (diploid Y1H) or the direct transformation (haploid Y1H) protocol. The 745 TFs in
Y1H-compatible AD-vectors are transformed into the yeast DNA bait strain or into the mating yeast strain for the transformation and the mating assays, respectively; the
colonies are then selected and four replicates are created by using a colony-pinning robot that transfers the 384 individually transformed yeast strains and spots them in a
square pattern. In the mating protocol, the mating yeast strains containing the respective TFs are mated with the yeast DNA bait strain and then selected to create diploid
yeast. Finally, in both protocols, TF–DNA bait interactions are identified based on growth on a selective 3-amino-1,2,4-triazole (3-AT)-containing yeast plate. The green
circles indicate positive protein–DNA interactions.
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13 (33%) out of 40 protein–DNA interactions were in common
revealing extensive interassay variability consistent with what
has been observed for yeast two-hybrid (Y2H) screens when
different yeast strains are used (Koegl and Uetz, 2007) (Table I,
last row, last column; Figure 2; Supplementary Table S3).
Interestingly, when the latter ‘consensus’ interactions were
retested using mating by re-transforming the respective TFs
into the mating strain, we obtained a lower validation
percentage for mating (70% or 9/13) versus direct transforma-
tion (92%or 12/13) (Supplementary Figure S8; Supplementary
Table S3, last row, columns three and six; Materials and
methods). This result is consistent with our earlier hypothesis
that re-transformation of the TFs into the mating strain lowers
the reproducibility, and suggests that re-performing a mating
screen with a second and independent yeast TF array may be a
more stringent validation strategy.Third, we found that 6 out of
15 transformation-specific and 6 out of 12 mating-specific,
reproducibly detected interactions were also found when
tested on an individual (i.e., not large-scale) basis with the
complementary Y1H approach (i.e., mating when originally



















Rhs7-2 element 10 13 6/10 0/2 7 7 7/7 0/2 3/10
M. musculus control region
of beta-globin locus
(Mlcrhs4 element)
9 15 9/9 0/1 3 3 3/3 0/1 3/9
Ptgs2 promoter 6 6 1/6 1/9 2 2 1/2 1/9 1/1
Pou5f1 promoter 6 11 3/6 3/7 9 9 8/9 4/7 3/8
Mcts2-Id1 enhancer
element
6 9 3/6 — 2 3 2/2 — 2/3
Fos promoter 14 11 3/14 0/4 3 3 2/3 0/4 0/5
Mmp9 promoter 5 7 3/5 1/5 2 2 2/2 2/5 1/4
Total interactors
(percentage)
56 72 28/56 (50%) 5/28 (18%) 28 29 25/28 (89%) 7/28 (25%) 13/40 (33%)
Figure 2 Network representation of the detected Y1H interactions. This network generated by Cytoscape (Smoot et al, 2011) shows the identified interactions between
the tested DNA baits (black diamonds) and the Y1H-detected TF interactors (circles). Consensus interactions are represented by solid lines. Interactions reproducibly
found by either transformation or mating are represented by dashed- or dotted lines, respectively. Interactors reported in the literature (Supplementary Table S2) are
highlighted in light blue. ‘P’ refers to promoter.
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found using transformation and vice versa). These results
indicate that, as expected, both large-scale screening proce-
dures are non-exhaustive (Supplementary Figure S8;
Supplementary Table S3, last row, columns two and five).
Fourth, when only considering reproducibly detected known
interactions, we obtained a sensitivity of 18% (5 out of 28)
and 25% (7 out of 28) for the transformation and mating
procedures, respectively (Table I, last row, columns four and
eight). These results are in line with previously reported
numbers in Y1H and Y2H screens (Deplancke et al, 2006a;
Braun et al, 2009; Hens et al, 2011; Reece-Hoyes et al, 2011a).
The reason for this small discrepancy in sensitivities between
the transformation and mating strategies is unclear and simply
may indicate that some of the interactions are more robustly
detected in a diploid background.
In general though, we can conclude that the two Y1H
screening procedures have a comparable detection perfor-
mance and feature a similar throughput, as they both could
theoretically accommodate several dozen DNA bait screens
per month. However, mating may nevertheless be the method
of choice for groups wishing to replicate the presented set-ups.
This is because, even though it requires more hands-on work
compared with automated direct transformation (haploid
Y1H), it does not require an elaborate robotic set-up and can
be more easily implemented in a laboratory setting.
Validation of Y1H-detected interactions using
motif scanning and luciferase reporter assays
To independently validate the detected interactions and to
assess the potential technical precision rate and sensitivity of
our Y1H assays, we first compared and contrasted our Y1H
results with those derived from motif scanning. For consis-
tency, we used a recently published high-throughput SELEX
data set by Jolma et al (2013) because it contains the largest
collection of high-quality PWMs for human and mouse TFs to
date. This allows us to bypass potential issues with the quality
of PWMs, which may vary depending on the input data or
method through which they were derived (Stormo and Zhao,
2010; Gordan et al, 2011; Medina-Rivera et al, 2011; Weirauch
et al, 2013).Wewere able to retrieve reliable PWMdata for 326
out of 750 TFs (43%) within our clone collection, based on the
fact that these TFs were directly probed or at least their one-to-
one human orthologs (Materials and methods). We then used
the widely applied method FIMO (Grant et al, 2011), which is
part of the MEME software package, to scan the seven bait
sequences for the presence of motifs at three different
detection stringencies including default parameters (Materials
and methods).
Our analyses revealed that using default scanning
parameters (Po1e-4), B50% of reproducibly detected Y1H
interactions are supported by respectivemotif hits (see the ‘all’
category and Y1H ‘positive predictive value (PPV)’ column in
Supplementary Table S4). This PPV, or the precision rate
(Materials and methods), increases toB90% when motifs are
called at lower stringency (Po1e-3), thus providing
in silico support for the majority of reported interactions. We
did not detect any clear emerging pattern regarding which Y1H
procedure is most robust, even though consensus interactions
tend to have the highest PPV value at high motif calling
thresholds. This indicates that interactions that are driven by
binding sites that closely resemble the consensus sequence
will likely be detected by both Y1H approaches. Interestingly,
the PPV values for our positive control interactions (i.e., those
reported in the literature) were only slightly higher than the
Y1H ones (Supplementary Table S4), indicating that reprodu-
cibly detected Y1H- and literature-based interactions feature a
comparablemotif occurrence probability. In addition, 16 out of
40 detected Y1H interactions were not predicted through motif
scanning. These 16 interactions are mediated by 10 TFs. For 2
out of these 10 TFs, PWMs are available within the Jolma et al
(2013) data set, yet motifs were not predicted within the
respective DNA baits (the Fos promoter and the Mlcrhs4
element for the TF BARX1 and the Mcts2-Id1 enhancer for the
TF ONECUT2). A further scan of other databases (TRANSFAC,
Wingender, 2008; JASPAR, Bryne et al, 2008; and UNIPROBE,
Robasky and Bulyk, 2011) revealed that PWMs appear to be
available for five out the remaining eight TFs. This leaves three
TFs (CDX4, NR2C1, and ZDHHC9) and four interactions that
would not have been detected through regular motif scanning,
next to the three interactions involving two TFs for which the
corresponding motifs could not be detected within the target
sequences despite the availability of the respective PWMs
(see also below).
However, many more motifs were called for which the
respective TF–DNA interactions were not detected using Y1H.
This is revealed when calculating the sensitivity, which
represents the percentage of motif-predicted TF–DNA interac-
tions supported by Y1H.We found that the sensitivity amounts
to B2–10% of all reproducibly detected interactions for,
respectively, low to high motif calling stringencies (the ‘all’
category in Supplementary Table S4). These numbers reflect
on the one hand the fact that motif scanning may itself be
prone to false positive calls of which the rate depends on the
type of algorithm, the quality of TF PWMs, or the scanning
parameters (e.g., detection threshold) used (Gordan et al,
2011; Medina-Rivera et al, 2011; Klepper and Drablos, 2013;
Weirauch et al, 2013), but on the other hand the likely
substantial technical false negative rate of the Y1H assay. One
possible reason for the low sensitivity of the Y1H assaymay be
the occlusion of binding sites by nucleosomes. In other words,
since the DNA baits are chromatinized, genuine binding sites
may not be accessible because of nucleosomal interference.
To test this, we predicted the nucleosome occupancy of each
DNA bait using the Kaplan et al (2009) model. All seven DNA
baits showed an overall high nucleosome occupancy land-
scape (Supplementary Figure S9; Materials and methods).
This suggests that many interactions which involve sites that
are predicted to be strongly occupied by nucleosomes are
nevertheless detected by Y1H. An example is the interaction
between the Mcts2-Id1 enhancer and RFX2 whose motif is
predicted to be located in a high nucleosome occupancy region
(P¼ 0.88). This observation is consistent with the PPV values,
which gradually decrease upon progressively excluding
regions within DNA baits that feature high (P40.7), moderate
to high (P40.5), or low to high (P40.3) predicted nucleosome
occupancy probabilities (Supplementary Table S5). In other
words, by removing regions within DNA baits with a moderate
to high predicted nucleosome occupancy, we remove many
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motifs that support detected Y1H interactions. However, we
observed an inverse relationship between sensitivity values
when we considered all Y1H interactions supported by high
stringency motifs. This suggests that sites that are predicted to
be weakly occupied by nucleosomes and have a high motif
score are more likely to be detected with Y1H. Provided that
the predicted data reflect true in vivo behavior, our analyses
point to nucleosome occupancy as another plausible factor
affecting the predictive value of our Y1H platform.
We further explored themolecular basis for the probable low
sensitivity of the Y1H assay, by testing whether the overall
motif load for a specific TF within a DNA element affects the
interaction detection probability. We found that the sensitivity
of the Y1H assay is indeed partially dependent on both motif
number and score in that the higher both are, the more likely
the respective interaction will be detected (Supplementary
Table S6). We conclude that the number of TF binding sites,
their score, and the nucleosome occupancy landscape are all
factors that influence the predictive value of the Y1H system.
To additionally validate the detected interactions and to
experimentally benchmark our Y1H assays, we also performed
systematic TF overexpression-based luciferase reporter assays
with all seven screened DNA elements in HEK293 cells. Of the
59 tested interactions including 26 known interactors and
33 novel Y1H-detected interactions, 40 (68%) significantly
(Po0.05, n¼ 6; Materials and methods) altered luciferase
activity (Figure 3A and B; Supplementary Figure S10;
Supplementary Table S3). Among the 40 luciferase-validated
interactions, 13 (out of 15 tested TFs, 87%) and 6 (out of 12
tested TFs, 50%) were found by only transformation or
mating, respectively, and 10 (out of 13 tested TFs, 77%) by
both approaches. Furthermore, out of 33 novel Y1H-detected
interactions, 26 (79%)were positive in HEK293 cells. Of the 19
known interactors that were not detected by Y1H, 11 (58%)
were positive (Figure 3C; Supplementary Table S3). These
results indicate that interactions detected by either one or both
Y1H screening strategies have a similar, if not greater,
likelihood of altering luciferase activity than those detected
by other methods, validating both presented Y1H approaches.
MITOMI-based analysis of regulatory elements
Yeast one-hybrid, motif scanning, and luciferase reporter
assays do not yield conclusive evidence that the tested TFs are
directly binding to their respective DNA elements. In addition,
while Y1H assays identify candidate interactors for DNA
elements, they do not provide positional information as to
where exactly these TFs bind within these relatively long (up
to 1 kb) DNA sequences. We therefore elaborated on our
recently developed microfluidics-based protein–DNA interac-
tion mapping approach, termed MARE, enabling the fine-
grained localization of TFs of interest within specific regula-
tory elements (Hens et al, 2011). The MARE technique can be
compared with a series of electrophoretic mobility shift assays
(EMSAs), in which a TF is tested for its ability to bind to a
collection of typically small DNA sequences, and relative DNA
occupancy data for each sequence can be derived (Figure 4A;
Materials and methods). Similarly to EMSA, the MARE
protocol starts with small DNA elements, resulting from the
fragmentation of long regulatory DNA sequences, which
are tested individually for binding to a specific set of TFs
Figure 3 Luciferase validation of Y1H interactions. Luciferase reporter-based validation with either the Mmp9 promoter (A) or the Mcts2-Id1 enhancer element (B),
respectively. The results for the other DNA baits can be found in Supplementary Figure S10. The fold change of the normalized firefly to Renilla ratio compared to the
normalized firefly to Renilla ratio of the negative control (empty expression vector) is plotted. Consensus interactions were analyzed as well as those reproducibly found by
either mating or transformation. Interactors reported in the literature (Supplementary Table S2) and not found in the Y1H screens were also tested. The error bars represent
the standard error of six independent biological experiments. **Po0.01 and 0.01o*Po0.05 compared with the negative control. (C) Proportion of reproducibly detected
transformation-, or mating-based interactions that scored positive in the luciferase reporter assay. As a comparison, the proportion of known interactions
(i.e., positive controls) that altered luciferase activity is also plotted. Source data for this figure is available on the online supplementary information page.
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(e.g., those that were identified using our Y1H screens).
However, MARE accommodates 4700 EMSA-like assays at
once on one microfluidic chip in a relatively straightforward
and cost-effective manner. This in turn enables the generation
of a relative DNA occupancy landscape for each TF of interest
over the length of the respective regulatory element where the
regions of highest occupancy likely contain the respective TF
binding sites (Figure 4B–D). Thus, MARE allows the simulta-
neous validation and localization of protein–DNA interactions
within regulatory elements.
To apply MARE for mouse protein–DNA interaction studies,
we tested several DNA bait- and protein expression formats,
resulting in the generation of a MARE-compatible vector that
enables the wheat germ (WG)-based in vitro expression of
GFP-tagged proteins (Supplementary Figure S11;Materials and
methods). Compared with our initial strategy (Hens et al,
2011), we also incorporated a multiplexer into our micro-
fluidics design to enable the simultaneous testing of multiple
off-chip produced TFs within the sameMARE assay (Materials
and methods). In this new strategy, each tagged TF is first
in vitro expressed in amicrocentrifuge tube (off-chip) and then
transferred in each specific chip row to test for binding to the
spotted DNA sequences (Figure 4A). The advantage of off-chip
synthesis is that it yields a larger protein amount relative to
on-chip protein expression, which increases the overall signal-
to-noise ratio and improves binding site resolution (Supple-
mentary Figure S12). We first benchmarked MARE by
analyzing the interaction between NFKB1 and the Mmp9
promoter. This is because there is solid evidence for one
specific NFKB1 binding site within the Mmp9 promoter based
on several assays including ChIP and PWM data
(Supplementary Table S2; Materials and methods). For this
purpose, we tiled the 998 bp-long Mmp9 promoter in
fragments of 36 bp, each overlapping 24 bp, allowing us to
examine the binding of NFKB1 to this element with a
maximum resolution of 12 bp. As shown in Figure 4B and
Supplementary Figure S13, the MARE-based DNA occupancy
landscape revealed two reproducibly detected and significant
binding peaks. One is exactly positioned within the NFKB1-
bound region identified by previously published methods,
while the second contains another predicted strong NFKB1
binding site. These results validated the MARE technique and
prompted us to analyze the interactions involving the six other
remaining known or Y1H-detected interactors with the Mmp9
promoter, that is, ETS1, ETS2, TCFAP2A, ZIC3, SP3, and SP4
(Supplementary Figure S13; Supplementary Table 2). Off-chip
expression of TCFAP2A was overall low and therefore not
tested further. ZIC3 exhibited strong site-specific binding as
indicated by the presence of one clear, motif-containing DNA
occupancy peak. For both ETS1 and ETS2, we identified three
consistent binding peaks by MARE, with the largest being
shared between the proteins and overlapping the previously
reported binding region (Figure 4C). However, similar to
NFKB1, we found that even the smaller and not necessarily
significant ETS1 and ETS2 MARE peaks tended to contain
predicted motifs. To more formally assess the molecular
relevance of this overlap, we plotted the MARE versus the
motif scores for each TF. This revealed that the MARE scores
follow the motif score landscape well (Supplementary Figures
S14 and S15). In fact, they do so for the majority of tested TFs,
although the correlation tends to deteriorate for very low
scoring motifs, many of which may therefore constitute false
positive calls. This is particularly well illustrated by the SP3
and SP4 MARE data (Supplementary Figure S14). Plotting
these data revealed more distributed (e.g., compared with
NFKB1), but largely overlapping DNA binding profiles
(Figure 5A; Supplementary Figure S13), whereby most peaks
contain predicted SP3 and SP4 DNA binding motifs. This
overlap is consistent with the highly conserved nature of the
DNA binding domains (DBDs) of all SP proteins (i.e., SP1, SP3,
and SP4) (Figure 5B) and with the observation that these
proteins can compete for the same DNA sites (Kaczynski et al,
2003). In sum, both TFs bind DNA in a correlated and site-
specific manner with a preference for SP-like motifs and this
DNA binding behavior is accurately captured by the MARE
assay.
Finally, we used MARE to validate and characterize Y1H
interactions detected with the orphan enhancer Mcts2-Id1.
Both RFX2 and SMAD4 showed site-specific binding in
MARE, again often overlapping with predicted binding sites
(Figure 4D; Supplementary Figure S16). The interaction
involving ONECUT2 is of special interest since it was not
predicted using motif scanning despite the availability of a
ONECUT2 PWM. However, we observed two reproducibly
detected peaks, providing additional support for the Y1H data.
We have listed the sequences through which ONECUT2 likely
interacts with theMcts2-Id1 enhancer in Supplementary Table
S7, which also features the sequences for interactions
involving other TFs (ETS1 and ETS2), which do not overlap
with predicted motifs. A more detailed dissection of these
sequences will now be required to identify the precise
molecular mechanisms and binding sites underlying the
observed TF–DNA interactions. For example, we observed
that a reproducibly detected ETS1 peak is not supported by a
motif call (Figure 4C; Supplementary Figure S13). Upon closer
inspection, we found that an ETS-like binding site is present,
but its probability (P¼ 1.2e-3) fell just below our lenient
detection threshold of Po1e-3. Intriguingly, when the under-
lying PWM was replaced by a model from TRANSFAC, the
motif was scored as significant (P¼ 2.2e-4), illustrating the
difficulty in obtaining an accurate snapshot of the DNA
binding landscape based on motif calling alone.
In conclusion, we found that four out of four testable,
known interactors (i.e., NFKB1, ETS1, ETS2, and SP3) and
nine out of nine Y1H-detected interactions showed at least one
site-specific, reproducibly detected binding peak, providing
strong support for the observed Y1H interactions as well as the
utility of the MARE assay to resolve DNA binding patterns for
specific TFs with DNA elements of interest.
In vivo validation of detected TF–enhancer
interactions
The approaches utilized above do not provide information
about whether the detected TF–DNA interactions take place
in vivo. Consequently, it would be optimal to obtain additional
data supporting their occurrence in a biologically relevant
context. First, given the remarkable DNA binding patterns
observed for SP3 and SP4 in the MARE assay (Figure 5A), we
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aimed to validate the binding of these TFs to the Mmp9
promoter by performing ChIP in NIH-3T3 cells using NFKB1 as
a positive control. Specifically, it was shown that NFKB1
interacts with theMmp9 promoter in NIH-3T3 cells after TNF-
a induction (Balasubramanian et al, 2011), and we therefore
tested for binding of SP3, SP4, and NFKB1 to Mmp9 by
Mammalian gene regulatory network mapping
C Gubelmann et al
8 Molecular Systems Biology 2013 & 2013 EMBO and Macmillan Publishers Limited
ChIP-qPCR in TNF-a-stimulated and unstimulated cells. We
confirmed binding of all three TFs to theMmp9 promoter after
TNF-a stimulation, whereas little to no binding could be
detected in unstimulated cells (Supplementary Figure S17).
The occurrence of multiple SP-like motifs within the Mmp9
promoter and the apparent recruitment of SP3/SP4 to those
homotypic binding sites is intriguing and implies either
additive/synergistic effects in the regulation of Mmp9 gene
expression or functional redundancy against deleterious
mutations (Maurano et al, 2012; Spivakov et al, 2012).
Interestingly, Pascal and Tjian (1991) revealed in a classic
study that adjacent SP1 binding sites promote the formation of
higher order SP1 complexes. These complexes are able to
interact more efficiently with the general transcriptional
machinery than individual SP1 proteins resulting in higher
transcription, thus lending support for the synergistic nature of
the detected SP3/4 binding events with the Mmp9 promoter.
In a second experiment, we decided to take advantage of the
information provided by the MARE assay to in vivo validate
protein–DNA interactions in a DNA-centric manner. For this
purpose, we focused on the Mcts2-Id1 enhancer as its activity
has been assessed in mouse embryos in the VISTA Enhancer
resource (Visel et al, 2007) at embryonic day (E) 11.5, revealing
expression in the eye, the forebrain, the midbrain, and the
hindbrain. Specifically, we set out to assess whether a small
region (B50bp) within this enhancer identified by MARE
analysis to contain or overlap with DNA occupancy peaks for
RFX2 and ONECUT2 is necessary for the observed expression
pattern of the enhancer (Figure 4D; Supplementary Figure
S16). This is because, even though this DNA segment exhibits
poorer sequence conservation compared with other segments
within this enhancer (Supplementary Figure S18), we made
several independent observations that all point to the
importance of this region in regulating the activity of the
Mcts2-Id1 enhancer through the RFX2 and ONECUT2 TFs.
First, we performed Y1H assays with the enhancer minus
the 50bp region (enhancer D50) and found that RFX2 and
ONECUT2 no longer bind to this deletion compared with the
Figure 5 Shared DNA occupancy landscape between SP3 and SP4 across the Mmp9 promoter element. (A) MARE-based analysis of Y1H-detected protein–DNA
interactions involving the TFs SP3 and SP4 and the Mmp9 promoter. For each replicate, the relative DNA occupancy values are plotted as described in Figure 4. SP3
replicate 1, SP3 replicate 2, SP4 replicate 1, and SP4 replicate 2 are represented by light blue, dark blue, orange, and brown lines, respectively. The PWM-based binding
site predictions for SP3 and SP4 proteins are indicated with blue and yellow bars. (B) Multiple protein alignment of the annotated SP1 DNA binding domain with SP3 and
SP4. Star symbols indicate identical amino acids across all three proteins. Amino acids highlighted in red indicate the proposed protein–DNA interaction residues of the
human SP1 protein (Oka et al, 2004). The SP1 DNA binding domain between human and mouse is highly conserved with only a single amino-acid change between both
proteins.
Figure 4 MARE pipeline and results. (A) Schematic picture of the MARE principle. Cy5-labeled, double-stranded DNA fragments derived from the regulatory element
of interest are spotted on an epoxy glass slide. The glass slide is then aligned with a MITOMI chip such that each microfluidic unit cell contains only one fragment of the
regulatory element. The expression templates coding for TFs were incubated off-chip with an ITT mix after which the resulting proteins were introduced in different rows
of the MITOMI chip using a multiplexer design. The dynamic protein–DNA interaction detection steps are described in the inlet. (1) The surface chemistry is derivatized as
described in Maerkl and Quake (2009) allowing the immobilization of biotinylated-GFP antibody at the center of the upper unit. (2) The in vitro translated protein is
introduced into the units. (3) The microfluidic chip is then incubated for 1 h to allow the thermodynamic equilibration of putative TF–DNA interactions. (4) TF–DNA
interactions are pulled down in the center region of the upper unit by the biotinylated GFP-antibody and then mechanically trapped by closing a microfluidically controlled
‘button’ membrane, which removes all surrounding solution phase molecules after washing. The TF (GFP) and DNA element (Cy5) fluorescence is then quantified with a
microarray-like fluorescent scanner, enabling the assessment of how much TF and DNA element is trapped. Note that here, only one protein binding to one DNA
fragment is visualized. This is a simplification as in reality many TFs are pulled down in each unit, and all of them are able to bind to the respective DNA fragments. (B–D)
Examples of MARE-based protein–DNA interaction analyses with individual fragments derived from the Mmp9 promoter element involving NFKB1 (B) and ETS1 (C) or
with fragments derived from the Mcts2-Id1 enhancer element involving RFX2 (D). Data for the other tested interactions are shown in Supplementary Figures S13 and
S16. Bound DNA levels normalized over surface-immobilized protein amounts are plotted for each 12 bp nucleotide stretch as small gray dots with horizontal lines
indicating the 12 bp region. Signals between every 12 bp nucleotide were determined by interpolation. Significant sequence-specific binding region peaks are pointed out
with a red line, while binding region maxima are highlighted with red dots. Peaks found in two independent experiments are marked by an asterisk. When applicable, a
ChIP-based region (ETS1 and ETS2; Wei et al, 2009) and position weight matrix (PWM)-based binding site predictions are indicated with purple and yellow bars,
respectively. The consensus NFKB1 binding region is indicated by a green bar.
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wild-type construct, in contrast to SMAD4, which binds
elsewhere in the enhancer as derived from our MARE analysis
(Figures 4D and 6A; Supplementary Figure S16). These results
clearly support the observation that this 50 bp region mediates
the binding of both RFX2 and ONECUT2 to the Mcts2-Id1
enhancer. Second, luciferase reporter assays revealed a
significant decrease in luciferase activity with the deletion
compared with the wild-type construct upon RFX2 or ONE-
CUT2 overexpression, again in contrast to SMAD4, providing
additional support for our observations (Figure 6B). Finally,
the involvement of RFX2 and ONECUT2 in controlling the
activity of the Mcts2-Id1 enhancer is intuitive as they are both
expressed between E10 and 11.5 in tissues in which the
enhancer also exhibits activity (EMAGE gene expression
database, Richardson et al, 2010; the Mouse Genome Database
(MGI 5.11, May 2012), Finger et al, 2011). For example, Rfx2
has been shown to be expressed in the forebrain, eye, and the
heart (among other tissues), whereas Onecut2 is also
expressed in the developing brain and the gut next to the
embryonic spinal cord and the dorsal root ganglion
(Richardson et al, 2010; Finger et al, 2011) (Figure 6C).
Given the multi-tiered evidence pointing to the role of
this 50 bp region in mediating Mcts2-Id1 enhancer activity,
we decided to test the in vivo impact of its deletion. First,
we analyzed the wild-type enhancer expression pattern via
lentivector-mediated transgenesis at E10.5 (Materials and
methods; Friedli et al, 2010), given the fact that both RFX2
and ONECUT2 were shown to be highly expressed at this time
point. Nine out of eleven transgenic embryos exhibited a
similar expression pattern with lacZ staining in the forebrain,
the nasal placode (part of the forebrain), the eye, the heart, the
dorsal root ganglion, and the limb which together closely
resembled the previously described expression pattern at
E11.5. We also observed expression in the embryonic gut,
which was not previously reported (Figure 6C; Supplementary
Figure S19). Interestingly, deletion of only 50bp substantially
altered this pattern as, for five out of eight embryos, we no
longer observed activity in the forebrain, the eye, the nasal
placode, the heart, and the future gut, regions in which at least
one of the two TFs of interest is also expressed (Figure 6C).
Together, these results support a model in which RFX2 and
ONECUT2 cooperate to regulate the activity of the Mcts2-Id1
Figure 6 RFX2 and ONECUT2 regulate the activity of the Mcts2-Id1 enhancer through a 50 bp region. (A). Manual transformation experiments of RFX2 and
ONECUT2 with either the wild type or the 50 bp deletion (D50, highlighted in purple) Mcts2-Id1 enhancer element. Yeast strains were spotted in quadruplet. Positive
interactions are highlighted in yellow and can be compared with a negative control (original pAD-DEST vector, termed ‘empty’ and indicated by a dashed square)
illustrating the background growth for each DNA bait. The baits were selected on 10 mM 3-AT. (B) Luciferase reporter-based validation with either the wild type or the
D50 enhancer element. HEK293 cells were transiently co-transfected with DNA bait reporter construct, each of the respective TFs, and the Renilla luciferase vector. The
fold change of the normalized firefly to Renilla ratio compared with the normalized firefly to Renilla ratio of the negative control (empty expression vector) is plotted. The
error bars represent the standard error of 10 independent biological experiments. 0.01o*Po0.05 compared with the wild-type construct. (C) LacZ staining results of
E10.5 transgenic embryos containing either the wild type (left) or the D50 (right) Mcts2-Id1 enhancer-lacZ reporter construct. The expression profiles of RFX2 and
ONECUT2 in the highlighted organs as derived from the literature are summarized by ‘þ ’ (expression) or ‘ ’ (no evidence of expression). These two embryos
contained two integrated lentiviral DNA copies each. f, forebrain; m, midbrain; np, nasal placode; h, heart; g, future midgut; drg, dorsal root ganglion. Source data for this
figure is available on the online supplementary information page.
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enhancer in several embryonic tissues through a small 50 bp
region with their specific, regulatory contributions depending
on the respective tissue.
Discussion
In this study, we established a comprehensive mouse TF ORF
clone collection in a versatile Gateway format, which we are
still actively expanding through gene synthesis of missing TF
ORFs. We anticipate that this resource will therefore soon be
similar in size to its human counterpart (Hu et al, 2009) and
feature a similar utility in enabling the implementation of
different techniques or experiments to study mammalian gene
regulatory networks.
Here, we used this resource to develop a cross-platform
pipeline to first detect and then characterize mammalian
protein–DNA interactions at relatively high throughput and
resolution (Figure 7). We believe that this pipeline has several
advantages over in silico protein–DNA interaction detection
approaches: first, our pipeline allows the screening of virtually
every TF while motif scanning is limited to those TFs for
which the DNA binding specificities (PWMs) have been
characterized. For example, 10% of our detected Y1H
interactions involved TFs for which to our knowledge no
PWM is available. Second, motif scanning is more complex
than may seem at first sight. For example, the quality of PWMs
is variable and several PWMsmay be associated with the same
TF (Stormo and Zhao, 2010; Gordan et al, 2011; Medina-Rivera
et al, 2011; Weirauch et al, 2013), as also shown in our
analyses, making it difficult to compile the most accurate or
comprehensive data set. Perhaps even more importantly,
about half of the detected Y1H interactions would have been
missed with default motif scanning parameters. One option
would be to lower the required motif score because almost all
detected Y1H interactions were supported by motifs detected
with a lower stringency and because the MARE and motif
scores correlate well. However, lowering the detection
threshold increases the motif overcalling risk, resulting in a
higher number of false positives. We found that the sensitivity
of the Y1H assay isB3% at a default motif calling stringency.
This means that B60 reactions are predicted per DNA bait
when the latter are scanned for motifs using a default
threshold. While the Y1H assay has likely a substantial false
negative rate (see also below), it is unlikely that all of these
predicted interactions constitute true positives due to
ambiguity in TF PWMs, motif scanning algorithms, motif
Figure 7 Schematic overview of the pipeline employed to deorphanize mammalian gene regulatory elements. The regulatory element of interest is first cloned (Step 1),
and then integrated into yeast to enable high-throughput Y1H screens leading to the identification of putatively interacting TFs (Step 2). In Step 3, MARE analysis is
performed to both validate (reflected by light blue check marks) and map the detected TF–DNA interactions (indicated by light blue boxes) within the respective
regulatory element. Finally, small binding regions of interest can be deleted to examine the relevance of these DNA segments in mediating the in vivo activity of the
regulatory element (Step 4).
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scanning detection thresholds, and background models.
Third, the points discussed above highlight the need for
experimentally validated motif predictions, which the Y1H
and MARE assays readily provide. A reasonable strategy
therefore may be to combine motif calling with Y1H screens to
yield the most comprehensive and robust set of protein–DNA
interactions. These can then be further characterized using the
MARE assay, highlighting the unique and complementary
nature of the presented pipeline compared with motif calling
alone.
We made several important observations regarding the
detection performance of the Y1H assay. Specifically, we found
that it has a low sensitivity (i.e., 18–25%, based on
interactions reported in the literature; and 2–10%, based on
motif scanning), but a high precision (B90%, based on motif
scanning). These observations suggest that themainweakness
of the Y1H assay may be its low sensitivity and not necessarily
its low precision as has so far been commonly assumed.
The low sensitivity is not unexpected as these values
fall within the range reported by other yeast-based
one-hybrid or two-hybrid studies (Deplancke et al, 2006a;
Braun et al, 2009; Chen et al, 2010; Hens et al, 2011;
Reece-Hoyes et al, 2011a). Indeed, there are several reasons
why the Y1H assay may fail to detect specific protein–DNA
interactions. For example, we showed that the nucleosome
occupancy landscape, the number of TF binding sites per DNA
bait, and score of motifs within DNA baits affect the detection
probability. Other causes for the low sensitivity may include
the inability to detect binding of TFs that require an interaction
partner (either another TF or a co-regulator) to bind to
DNA, no or low expression of certain mouse TFs in the DNA
bait-containing yeast cells, and the fact that some of the
interactions may involve a specific TF isoform, which is
not included in our TF ORF library. In addition, the post-
translational modification (PTM) state of a protein expressed
in the yeast cell compared with the endogenous condition
may be different. Several types of PTMs such as phosphoryla-
tion (e.g., Rivera et al, 1993; Cowley and Graves, 2000;
Lee et al, 2010), sumoylation (e.g., Chou et al, 2007; Wei et al,
2007; Yan et al, 2010), and acetylation (e.g., Hayakawa et al,
2004; Sun et al, 2009; Waby et al, 2010) have been shown
to influence TF binding. In this regard, it is interesting that
PTMs of at least two TFs involved in three positive control
interactions that were not found by the Y1H screen have been
shown to influence DNA binding of these TFs (i.e., acetylation
of GATA1, Lamonica et al, 2006; sumoylation of POU5F1,
Wei et al, 2007). Nevertheless, our estimation of the sensitivity
is also highly influenced by the quality of the reported
interactions, which we consider as positive controls. Indeed,
in contrast to protein–protein interaction detection assays
(Braun et al, 2009), there is currently no gold standard
collection to evaluate the efficacy of protein–DNA interaction
detection methods. It is therefore conceivable that some
of the interactions that were not recovered by Y1H, and that
we count as false negatives, are in fact false positives from
another study. Our observation that interactions retrieved
from the literature do not show a greater validation frequency
in luciferase reporter assays and only have slightly greater
precision rates compared with all reproducibly detected
Y1H interactions is consistent with this view. We therefore
believe that our reported sensitivities are conservative
estimates.
The precision of Y1H assays had so far not been system-
atically assessed, but has typically been predicted to be low.
Here, we provide evidence that, at least from a technical point
of view, this rate is likely high. First, we found that themajority
of detected interactions involve TFs whose corresponding
binding sites are present in their respective DNA baits. Second,
we tested the interactions using luciferase-based cell-culture
assays. While we cannot exclude that some of the observed
reporter expression changes were due to indirect effects, our
results nonetheless suggest that the majority of tested protein–
DNA pairs can also interact in mammalian cells. Third, we
evaluated and characterized Y1H-detected interactions using
the microfluidics-based MARE assay, which we show tracks
the DNA binding behavior of TFs well. Similarly to the
luciferase-based assay, we were again able to validate most
interactions based on the fact that we observed sequence-
specific binding of identified TFs with the respective DNA
elements. These results indicate that the majority of Y1H-
detected interactions can be corroborated by in silico, in vitro,
as well as cell culture-based assays, and that at least from a
biochemical point of view, most of the Y1H-detected interac-
tions appear to be true positives.
Whether these interactions also occur in vivo is more
difficult to systematically assess as interactions may for
example take place in only a few cells, or during only a brief
time period (Deplancke, 2009). Nevertheless, we provide
experimental evidence that at least several novel Y1H-
identified interactions have potential in vivo relevance,
notably those involving the Mmp9 promoter and the Mcts2-
Id1 enhancer. The latter regulatory element is located between
B0.7 and 1.4 kb upstream of the gene coding for the HLH
domain-containing inhibitor of DNA binding 1 protein, Id1,
and yields a virtually identical expression pattern as Id1 based
on findings by Jen et al (1996), suggesting that it mediates its
transcription. Here, we exploited the mapping resolution
offered by MARE to delineate a small DNA segment within
this enhancer, which controls the in vivo activity of this
regulatory element. Interestingly, conservation analysis would
not necessarily have identified this specific DNA segment,
since it exhibits poorer conservation than its surrounding
sequences. This observation appears consistent with the
findings from the ENCODE project which also reportedmodest
base pair overlap between experimentally derived and con-
servation-based regulatory annotations (Encode Consortium,
2007). Using our Y1H assay, we identified two TFs binding to
this small DNA region: (1) RFX2 is an RFX-type winged-helix
domain-containing transactivator (Horvath et al, 2009), which
is still poorly characterized, despite being expressed in a wide
range of tissues as indicated above; (2) ONECUT2 is a
homeodomain-containing TF, which, similar to RFX2, is
expressed in many tissues. However, their expression patterns
do not completely overlap, nor with those of the enhancer or
Id1, suggesting that, while we cannot exclude cooperativity in
some tissues, they each may individually contribute to the
activity of the enhancer (and by extension the expression of
Id1) in specific tissues such as the heart (RFX2) and the gut
(ONECUT2). The involvement of ONECUT2 in regulating gene
expression in the developing gut is supported by recent studies
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reporting the delineation of specific antero-posterior regions
by this TF, its presence in several gut cell types later in
development, and altered intestinal gene expression in One-
cut2 knockout mice (Vanhorenbeeck et al, 2007; Dusing et al,
2010). Together, our data point to a role for ONECUT2 in
controlling gut expression of Id1, which itself acts as a pro-
proliferative and tumorigenic factor in this tissue (Ruzinova
and Benezra, 2003). Another TF binding to the Mcts2-Id1
enhancer, albeit not to the same region as ONECUT2 and
RFX2, is SMAD4. Interestingly, SMAD4 has already been
shown to control the expression of the human Id1 gene, so it
appears reasonable to assume that this regulatory interaction
also occurs in the mouse (Katagiri et al, 2002). Thus, the data
presented in this study strongly support the in vivo relevance of
all three detected interactions involving RFX2, ONECUT2, and
SMAD4 with the mouse Mcts2-Id1 enhancer. In addition, they
reveal how a small, poorly conserved DNA segment within the
Mcts2-Id1 element is responsible for expression activity in
multiple tissues through distinct TF configurations, providing
interesting insights into the regulatory architecture of enhancers.
We also found evidence supporting the validity of other
detected interactions. For example, we observed binding of the
closely related forkhead TFs FOXJ2 and FOXJ3 to the DNase
I-hypersensitive site HS 4 of the locus control region (LCR) of
the b-globin locus. This LCR not only regulates the expression
of b-globin, but also of e-, Gg-, Ag-, and d-globin. Interestingly,
siRNA-mediated knockdown of human FOXJ2 in K562 cells
decreased expression of g-globin mRNA in this cell line (Yang
et al, 2009), consistent with our observation that this TF
upregulates LCR HS4-mediated luciferase expression. These
data therefore suggest that the interactions between FOXJ2 and
possibly FOXJ3 and b-globin LCR HS4 as observed in our Y1H
assay have in vivo relevance. Finally, we also detected binding
of the homeobox TF CDX4 to the same DNase I-hypersensitive
site of the control region of the b-globin locus. As there are
numerous reports for the role of CDX4 in hematopoiesis (e.g.,
Wang et al, 2005; Bansal et al, 2006; Lengerke et al, 2007), it is
plausible that this TF directly regulates the expression of one
or more globin genes, given their importance in red blood cell
function.
In conclusion, we believe that the presented two-tiered
approach provides a valuable strategy to identify and
characterize protein–DNA interactions with regulatory ele-
ments of interest that may be relevant in vivo. The resulting
data can then be used to generate and model gene regulatory
networks, which should be of great value to decipher the
regulatory grammar underlying mammalian gene expression.
Materials and methods
Gateway cloning of mouse TF ORFs
The first step toward the generation of the mouse TF ORF clone
resource was to create a comprehensive list of predicted mouse
TF-coding genes. Using data from the DBD database (Wilson et al,
2008) and from a complementary study (Gray et al, 2004), which also
aimed at identifying all sequence-specific DBD proteins, we predict
that the mouse genome contains 1576 TF-coding genes. We were able
to retrieve cDNA templates for 1260 of these from various sources,
including the FANTOM Consortium (RIKEN, Japan), Source
Bioscience (UK), and Open Biosystems (USA). To initiate the cloning
of the corresponding ORFs, we first applied a strong selection scheme
choosing the longest ORF per TF containing the respective DBD.
Specifically, we confirmed the presence of a DBD by screening the
longest ORFs against a subset of the Pfam protein database containing
predicted DBDs (E-valueo0.01). Accepted longest ORFs were then
compared with corresponding sequences in the RefSeq database
(Release 28). In most instances, the sequences matched perfectly.
However, in particular cases, manual curation and sequence adjust-
ment were necessary to ensure correct frame reading as well as
sequence completeness. After filtering, 1218 TF cDNA templates were
retained. TF ORFs without the stop codon were then PCR amplified as
described (Hens et al, 2011), using primers containing the attB1 and
attB2 gateway tails at the 50 end of the forward and reverse primer,
respectively (sequences are listed in Supplementary Table S1). When
the PCR amplification using cDNA clones as template was reprodu-
cibly not successful, an RT–PCR strategy was adopted to retrieve
additional TF ORFs by extracting total RNA from mouse 3T3-L1 cells
using the RNeasy mini kit (Qiagen). One microgram of total RNA
was used as an input to generate cDNA using the SuperScript III
First-Strand Synthesis kit (Invitrogen). Successfully PCR-amplified
TF ORFs were cloned into the pDONR221 vector using Gateway
cloning by mixing 100 mg of the pDONR221 vector, 2ml of the PCR
product, and 0.5ml of BP clonase II enzyme mix (Invitrogen). After
incubating for 18 h at 251C, this mix was transformed into competent
DH5a cells and single colonies, typically six per TF, were analyzed by
colony PCRwithM13FandM13R primers using standard protocols. The
TFs that were successfully cloned in pDONR221 (further called TF entry
clones) were subsequently analyzed by high-throughput sequencing.
High-throughput sequencing of TF clone ORFs
Library preparation, high-throughput sequencing, and data analysis
were performed as described (Hens et al, 2011). Briefly, TFentry clones
were pooled equimolarly and fragmented. Sequencing libraries were
prepared with these fragments and sequenced using the Illumina
Genome Analyzer II DNA Sequencing Platform (Illumina). The output
data were processed using the Genome Analyzer Pipeline Software
v1.4 and the resulting file containing the short reads was submitted to
the WebPrInSeS server (Massouras et al, 2010) together with a file
containing the reference sequences for the assembly of the short reads
and evaluation of the resulting ORFs in comparisonwith the respective
reference sequences. After the analysis, the clones were labeled as
‘Gold’, ‘Silver’, and ‘Bronze’ depending on their sequence quality.
Clones were rejected if they contained partial ORFs, non-sense
mutations, missense mutations in a known functional protein domain
or more than five missense mutations in total compared with the
reference sequence. ‘Gold’ clones (715 clones) are fully covered by
sequencing,‘Silver’ clones (35 clones) have the 5’ and 30 ends covered
by sequencing (i.e., standard ORFeome quality) and finally ‘Bronze’
clones were only partially sequenced.
Shuttling the TF ORFs to Gateway compatible
AD vectors
The 750 TF ORFs, labeled as ‘Gold’ and ‘Silver’ (labels explained in the
high-throughput sequencing section), were subcloned from the TF
entry clones into an equimolar mix of pAD-Dest-ARS/CEN and AD-
Dest-2m by mixing 2 ml of the TF entry clone, 100 ng of the pAD-Dest
mix and 0.5 ml of LR clonase II enzyme mix (Invitrogen). After
incubating for 18 h at 251C, this mix was transformed into competent
DH5a cells. Successfully subcloned TFs (745) were miniprepped using
the NucleoSpin 96 Plasmid miniprep kit (Macherey-Nagel), typically
yielding a concentration ofB100–160 ng/ml and arrayed into two 384-
well plates (Supplementary Table S1). Some of the empty wells in the
two 384-well AD-TF plates were filled with the original pAD-DEST
vectors as negative controls.
Cloning of the DNA baits
DNA baits were PCR amplified using primers containing restriction
enzyme recognition sites at the 50 end of the forward and reverse
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primer, respectively (Supplementary Table S2), cloned in the pENTRY-
50 vector using standard restriction-ligation techniques and transferred
byGateway LR cloning into the pMW2 (‘HIS3’) vector (Deplancke et al,
2006b). Genomic integrations of the DNA bait-reporter constructs in
the YM4271 yeast strain (Deplancke et al, 2004) were performed using
lithium acetate (LiAc)–polyethylene glycol (PEG) transformation
followed by selection on corresponding selective plates. Note that
we opted not to include a second reporter such as lacZ but rather to use
growth on selective medium and reproducibility as our main criteria to
call positives. This is because results from Y1H-based protein–DNA
interaction screens in Drosophila revealed that the lacZ reporter often
yielded a set of positives that entirely overlapped with the HIS3-based
list of consensus interactions (Hens et al, 2011). Moreover, we found
the lacZ reporter to be less sensitive than HIS3 as it for example failed
to detect interactions for which we obtained clear evidence that they
are relevant in vivo.
Selection of the positive controls for DNA bait
interactions
TheDNA baits were selected based on their involvement in at least one
TF–DNA interaction for which there is strong experimental evidence
based on the existing literature (Supplementary Table S2). For each
promoter, positive control interactions were retrieved from the TRED
database (last query was performed at the end of June 2011; Jiang et al,
2007) by selecting promoters by gene name on the promoter retrieval
webpage. Specifically, all papers associated with the respective
promoters listed in TRED were browsed and positive interactions
were added if supporting experimental data were available for these
interactions in the respective papers. Interactions for LCRs (e.g., of the
b-globin gene) were obtained by extensively browsing the correspond-
ing literature. Enhancer elements were randomly selected from the
VISTA Enhancer Database (Visel et al, 2007)with the sole criterion that
they exhibited in vivo enhancer activity (Supplementary Table S2).
Automated, large-scale yeast transformation
Yeast transformation was performed as described (Hens et al, 2011).
Briefly, after transformation, yeast strains were allowed to grow for
3 days at 301C on permissive plates before the colonies were
transferred onto selective plates containing varying 3-amino-1,2,4-
triazole (3-AT) concentrations (typically from 5 to 20mM) using the
RoToR HDA robot (Singer Instruments). During this transfer, each
colony was quadruplicated in a square pattern, yielding four technical
replicates and facilitating detection of positive interactions. The plates
were typically analyzed after 5–7 days of incubation at 301C.
Mating protocol
Mating experiments were performed as described previously (Walhout
et al, 2000; Vermeirssen et al, 2007). Briefly, the two 384-well AD-TF
plates were transformed into the Ya1867 strain (a kind gift from John
Reece-Hoyes and Marian Walhout, University of Massachusetts
Medical School, USA). The transformed yeasts were spotted on Sc-
Trp plates and were allowed to grow for 2 days at 301C. Each colony
was then spotted four times to create a 1536 array of transformed yeast
on Sc–Trp plates using a RoToR HDA robot (Singer Instruments).
Glycerol stocks were prepared for each transformant, and fresh plates
were grown from these glycerol stocks every 2months to avoid cross-
contamination caused by repeated replication of the yeast colonies.
Two days before the mating, a lawn of the DNA bait strain was
prepared on YPD plates and the two AD-TF plates were freshly
replicated on Sc–Trp plates. Mating was performed by transferring the
AD-TF colonies onto a YPD plate and printing the DNA bait strain on
top. The mating plates were left overnight at 301C before transferring
the mated yeast to plates selecting for yeast containing both the
reporter construct and the respective TF after which these plates were
incubated for 2 days at 301C. The resulting diploid yeast colonies were
then transferred onto selective plates containing varying 3-AT
concentrations (usually 5 and 10mM). The plates were typically
analyzed after 5–7 days of incubation at 301C.
Semi-automated detection of positive interactions
To avoid biases associated with the manual calling of putative positive
interactions, selective plates were analyzed using the TIDY software
developed by Hens et al (2011), which enables the semi-automated
detection of positives. Briefly, interactions of which the convoluted
growth score of the respective TF yeast quadrant scored 20%above the
highest background intensity value were retained. In roughly one third
of the called interactions, this default threshold was lowered to 10% to
include positives that bordered the cluster of called positives and that
as such still clearly exhibited superior growth than the highest
background levels.
Transient transfection and luciferase assays
For cloning convenience, a Gateway-compatible pGL3-promoter
vector was created by digesting the pGL3-promoter vector (Promega)
with acc651I and BglII, and blunting the resulting sticky ends using
standard techniques. The Gateway AttR4-AttL1 cassette was dropped
from the pMW2 vector using SpeI and SacII, blunted, ligated into the
linearized pGL3-promoter vector and transformed into DB3.1 ccdB-
resistant cells. The DNA baits were subcloned from the pENTRY-50
vector into the Gateway-compatible pGL3-promoter vector using a
Gateway LR reaction as described under the section ‘Shuttling the TF
ORF to Gateway compatible AD vectors’.
TFs were subcloned by a Gateway LR reaction into a Tet-On Gateway-
compatible expression vector (a kind gift fromAndrea Corsinotti, EPFL,
Switzerland).We did not obtain clones for two positive control TFs, Ahr
and RXRa, explaining why only 26 and not 28 positive control
interactions were tested. One day before transfection, 2.10e4 HEK293T
cells were plated on 96-well flat clear bottom white polystyrene plates
(Sigma) coated with poly-D-lysine hydrobromide (Sigma) according to
the manufacturer’s protocol. Before transfection, the medium was
changed to a low antibiotic Dulbecco’s modified Eagle’s medium (with
0.1% of penicillin/streptomycin) containing doxycycline (1mg/ml,
Sigma). Cells were transiently transfected with the DNA bait- and TF-
containing clones, together with a Renilla reporter vector (pRL-SV40,
Promega) to normalize for transfection efficiency. The transfection
mixturewas as follows: 550ng of DNA bait, 400 ng of the TF-expression
vector, 50ng of Renilla reporter vector, supplemented to 50ml with
OPTI-MEM (Invitrogen) and 2.5ml of FuGENE HDTransfection Reagent
(Promega). Forty-eight hours after transfection, the cells were washed
with PBS solution, lysed, and luciferase activitywasmeasured using the
Dual-Luciferase Reporter Assay System (Promega) on an Infinite f500
microplate reader (Tecan) according to the manufacturer’s protocol.
Luciferase activity was normalized using the Renilla luciferase activity
measurements for each well. Data were calculated as fold change in
RLU versus the activity of the negative control (i.e., empty TF-
expression vector). Luciferase data are based on six or ten independent
biological replicates (i.e., a well of cells that were independently
transfected with the reporter constructs, lysed, and prepared for
measurement) from which outliers were excluded using the fourth-
spread method. The standard error of fold change is computed for all
TFs according to the rules of error propagation.
MITOMI-based analysis of regulatory elements
MARE was performed according to the protocol developed for the
MITOMI technology, including the design and fabrication of the molds
for microfluidic devices and the devices themselves (Maerkl and
Quake, 2007, 2009). To examine DNA elements using MARE, we first
explored different strategies to divide long sequences into shorter
fragments. Balancing overall throughput with the provided binding
site detection resolution, we found that the most optimal library
consists of 36 bp sequences covering the DNA element including 24 bp
up- and downstream of the element so that each 36 bp fragment has a
24 bp overlap with the next one in the library, and that each 12 bp
region is covered by three different fragments except for the first two
and last two fragments which are covered only twice. We also flanked
each fragment by a CCC clamp at the 50 end to prevent degradation
and by a complementary sequence at the 30 end to allow primer
hybridization. All fragments were obtained as single-stranded
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oligonucleotides from Life Technologies. These oligonucleotides were
subsequently used to generate labeled double-stranded DNA targets as
described previously (Maerkl and Quake, 2007).
To enable the off-chip expression of TFs and their fluorescence-
based detection, we again explored different strategies. We found that
the WG in vitro transcription translation expression system containing
translation enhancer (TE) sequences from the barley yellow dwarf
virus (BYDV) (Promega) yielded the most robust and reproducible
protein expression. To make this expression system compatible with
our mouse TF ORF clone resource and to allow the fluorescence-based
detection of TFs, we generated a novel vector, pMARE (Supplementary
Figure S11), by cutting the pF3AWG (BYDV) Flexi vector (Promega)
with NcoI and DraI, thereby removing the barnase cassette. The
Gateway reading frame A cassette (Invitrogen) was ligated in by the
use of blunt-end cloning. Subsequently, the eGFP coding sequence
(EUROSCARF) containing a stop codon at the 30-end was incorporated
between the KpnI and SacI restriction sites using standard cloning
techniques. TFs were then subcloned from the entry clones into the
pMARE vector by standard Gateway cloning. Linear expression
templates containing the 50 and 30 UTR sequences as well as the TF
ORF fused with the eGFP coding sequence were generated by PCR.
Primers for PCRwere designed through the Primer3Plus web application
(http://www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi;
Fw: GTATCCGCTCATGGATCTCGATC, Rv: CGGTTTTATGGACAGCAAGC
GA). Briefly, the PCRs contained 5rmol of each primer, 100ng of
expression plasmid, 200mmol of each dNTP, and 1 unit of iProof High-
Fidelity DNA Polymerase (Bio-Rad) in a final volume of 50ml. The
reaction was cycled for 2min at 981C, followed by 35 cycles of 981C for
15 s, 601C for 30 s and 721C for 2min, followed by a final step of 5min at
601C. Each PCR was performed four times after which the resulting PCR
products were pooled, PCR purified, and subsequently used as a linear
expression template in a MARE experiment (Figure 4A).
All labeled double-stranded oligonucleotides were spotted onto an
epoxy-coated glass slide (CELL Associates) with a SpotBot3 micro-
arrayer (Arrayit) using a 946MP4pin (European BiotekNetwork SPRL).
The spotting protocol was done as follows: target DNA in 0.5% BSA
aqueous solution was spotted first. Thus, each resulting spot consisted
of a specific DNA fragment of the regulatory element (Figure 4A). TF
proteins were synthesized by the use of the TnT SP6 High-Yield Wheat
Germ Protein Expression System (Promega). The device alignment,
surface chemistry, MITOMI, and data extraction were performed
according to Maerkl and Quake (2007), except that an anti-GFP
antibody was used to pull down the tagged TFs and that a multiplexer
design was implemented to allow analysis of off-chip-expressed TFs
(Rockel et al, 2013). For each 12bp region, the average signal S of the
three fragments in which it is represented was determined. For each
12bp region, we defined the mid position as the representative binding
event position. Signal values between representative binding event
positions were approximated by cubic interpolation (interp1 function,
signal package, R). Specific TF–DNA interactions were detected by
clustering the signal of each position into two distinct classes, that is,
specific binding positions (SBPs) and non-specific binding positions
(NSBPs), using the k-means clustering algorithm (kmeans function,
R; settings: centers¼ 2, algorithm¼Hartigan-Wong, nstart¼ 1000).
We subsequently defined the center of the NSBP class as the DNA
bait-specific mean background signal (MBS). For each SBP, we defined
the relative enrichment over non-specific binding as E(SBP)¼ S(SBP)/
MBS and removed SBPs with an E of o2. Specific binding regions
(SBRs) were detected by grouping consecutive SBPs, and SBR maxima
were defined as the SBPs with the largest enrichment within an SBR.
Each MARE experiment was independently reproduced. We defined a
peak as reproducibly detected when the SBR maximum of the first
replicate overlapped with the SBR of the second replicate and vice
versa. For visualization, we scaled the y axis in Figures 4 and 5 and
Supplementary Figures 12, 13, 16 by dividing the DNA occupancy
signal of each 12bp DNA element by the maximal signal observed
across all 12 bp DNA elements.
In silico prediction of TF–DNA interactions
DNA baits were scanned for putative TF–DNA interactions using the
FIMOmotif scanning algorithm (Grant et al, 2011) using three different
stringency settings (Po1e-3, Po1e-4 (default), and Po1e-5). PWMs
were obtained from Jolma et al (2013). This data set contains 830
binding profiles for both human and mouse TFs as well as for full-
length TFs and TF DBDs only.We therefore first curated this PWMdata
set to have an unambiguous representation of the binding specificities
for our mouse TF clone collection. First, we only considered PWMs
derived from full-length proteins for cases where both the full-length
proteins and DBDs were probed. Second, we only considered mouse
PWMs when data for both the human and mouse TF versions were
available. Finally, when PWM information was available for human
TFs only, we assessed the human-mouse orthology status and only
considered PWMs derived from one-to-one orthologs as assessed by
ENSEMBL (type ‘ortholog_one2one’). For the MARE binding site
analysis, we also retrieved PWMs from TRANSFAC (www.
gene-regulation.com) for the TFs SMAD4 (V$SMAD4_Q6), ETS1
(V$ETS1_B), and ETS2 (V$ETS2_Q6). TF binding sites for MARE
occupancy profiles were predicted with a P-value threshold of Po1e-3.
To benchmark our Y1H assay, we calculated the PPV (or precision
rate), that is, the fraction of Y1H TF–DNA interactions that are
supported by a motif hit, and sensitivity, that is, the fraction of
motif hits detected by Y1H, for different Y1H interaction sets
(Supplementary Table S4).
Nucleosome position analysis
We scanned all seven DNA baits for nucleosome positions with the
Kaplan et al (2009) model (Supplementary Figure S9). We used the
online version with default settings and 1 kb flanking regions from the
pMW2 vector to account for boundary effects (http://genie.weizmann.
ac.il/software/nucleo_prediction.html). We arbitrarily defined DNA
positions as having a low-to-high (P-occupied40.3), moderate-to-high
(P-occupied40.5), and high probability (P-occupied40.7) for nucleo-
some occupancy. Y1H PPV and sensitivity scores were calculated for
DNA regions that were not occupied by nucleosomes at a respective
occupancy probability. Specifically, if at least one residue of a binding
site has a nucleosome probability above a certain threshold, then this
site is no longer considered ‘detectable’ by Y1H.
ChIP assays in NIH-3T3 cells
NIH-3T3 confluent cells were incubated overnight in serum-free
medium and were stimulated with or without 10 ng/ml mouse TNF-a
for 3 h (Life technologies). The cells were fixed as described previously
(Raghav et al, 2012) and stored at  801C. Five million cells were used
for each immunoprecipitation (IP) and were lysed and sonicated as
described previously (Raghav et al, 2012). After having estimated the
chromatin concentration using a NanoDrop, an equal amount of
chromatin for a control IP (rabbit control IgG) and specific antibody IP
was taken. The chromatin samplewas adjusted to 1ml for each IPwith
the ChIP dilution buffer (1.2mM EDTA pH 8.0, 16.7mM Tris–HCl pH
8.0, 1% Triton X-100, 167mMNaCl and 0.1% SDS containing protease
and phosphatase inhibitors) after which the chromatin sample was
incubated overnight at 41Cwith each respective antibody (SP3: sc-644;
SP4: sc-645; NFKB1: 50% ab7971 and 50% SC-372; 5mg per IP) and a
rabbit control IgG (Santa Cruz, sc-8994) coupled to magnetic sheep
anti-rabbit IgG Invitrogen Dynabeads, as described (Myers Lab ChIP-
seq Protocol, v041610.1 and v041610.2; http://www.hudsonal-
pha.org/myers-lab/protocols/) with few modifications. Specifically,
50ml of antibody-coupled beads was added to each 1ml chromatin
sample instead of 100ml. After incubation, the beads were washed five
times with a LiCl wash buffer (100mMTris at pH 7.5, 500mMLiCl, 1%
NP-40, 1% sodium deoxycholate) through mixing for 10min at 41C
after which a 1-minmix at 41Cwas used to wash the beads with 1ml of
TE (10mMTris–HCl at pH 7.5, 0.1mMNa2EDTA). The beadswere then
re-suspended in 200 ml IP Elution Buffer (1% SDS/0.1M NaHCO3),
incubated in a 651C shaker for 1 h and placed on a magnet to recover
the supernatant. The supernatant was incubated at 651C overnight to
complete the reversal of the formaldehyde crosslinks. The next day,
DNA was purified from the reverse-crosslinked chromatin using
proteinase and RNase digestion as well as Qiagen DNA purification
columns. The purified DNAwas eluted in 30ml of Qiagen elution buffer
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and stored at  201C until verification of ChIP enrichment by qPCR.
The following sense and antisense primers for the Mmp9 promoter
were used: Fw_TCTTTCCTTCCCCAAGGAGTand Rv_CCATCCCCACAC
TGTAGGTT. One intergenic genomic region was chosen as a negative
control as also described in Raghav et al (2012) with the following
primers: Fw_CACACAGCTGACCTCCAGAA and Rv_ AGTGGCAAGGTC
TCTGCTTC. The fold change between the boundMmp9 promoter and
the negative control was calculated for each IP.
Lentiviral vector mediated transgenesis
We cloned theMcts2-Id1 enhancer element in a LacZ reporter lentiviral
vector construct containing a minimal promoter (gateway pRRLbLac,
Friedli et al, 2010; Delpretti et al, unpublished). The lentivirus
productions and the injections were performed as described in
Friedli et al (2010). After the lentiviral vectors were injected in
fertilized oocytes, we harvestedmouse embryos at embryonic day 10.5
and observed enhancer expression by X-gal staining, according to
standard protocols. The injection efficiency was determined by qPCR,
after extracting the DNA from the yolk sac using a DNeasy blood and
tissue kit according to the manufacturer’s recommendations, as also
described previously (Barde et al, 2011).
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
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